- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Advanced neuroendocrine tumours of non-pancreatic origin
Total 429287 results
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruiting
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Merck Sharp & Dohme LLCCompletedHead and Neck Squamous Cell Carcinoma | Metastatic Renal Cell Cancer | Recurrent Head and Neck Carcinoma | Recurrent Lung Carcinoma | Recurrent Renal Cell Carcinoma | Recurrent Skin Carcinoma | Stage III Renal Cell Cancer | Stage IV Lung Cancer | Stage IV Skin MelanomaUnited States
-
AstraZenecaActive, not recruitingLocally Advanced or Metastatic Solid TumoursUnited States, Spain, Canada, Korea, Republic of
-
Merck Sharp & Dohme LLCCompletedMerkel Cell CarcinomaUnited States, Australia, Canada, France, Italy, New Zealand, Spain, Sweden
-
AstraZenecaActive, not recruiting
-
UNICANCERMerck Sharp & Dohme LLC; National Cancer Institute, France; Ligue contre le cancer...CompletedSarcoma | Neoplasms, Germ Cell and Embryonal | Carcinoma, Neuroendocrine | Ovarian Neoplasm | Central Nervous System Neoplasm | Thyroid Neoplasm | NK/T-cell LymphomaFrance
-
Crescendo Biologics Ltd.University Medical Center GroningenActive, not recruitingAdvanced and/or Metastatic Solid TumoursNetherlands
-
National Cancer Institute (NCI)CompletedAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Ovarian Carcinoma | Pancreatic Neuroendocrine Tumor | Unresectable Solid Neoplasm | Fibrolamellar CarcinomaUnited States
-
Canadian Cancer Trials GroupPfizerActive, not recruitingAdvanced Rare TumoursCanada
-
Jazz PharmaceuticalsCompletedAdvanced Solid Tumor | Metastatic Solid Tumor | Urothelial Cancer | Poorly Differentiated Neuroendocrine Carcinomas | Homologous Recombination Deficient-Positive Malignancies AgnosticUnited States
-
Regeneron PharmaceuticalsBristol-Myers SquibbCompletedMelanoma | Metastatic Melanoma | Unresectable Melanoma | Advanced MelanomaUnited States
-
SanofiActive, not recruitingMalignant Melanoma | Squamous Cell Carcinoma of SkinGermany, Spain, France, Chile, United States, Australia, Italy
-
TuHURA Biosciences, Inc.Dana-Farber Cancer Institute; University of Southern California; H. Lee Moffitt... and other collaboratorsActive, not recruitingMerkel Cell Carcinoma | Cutaneous Squamous Cell Carcinoma | Non-Melanoma Skin CancersUnited States
-
Seagen Inc.Merck Sharp & Dohme LLCActive, not recruitingMelanoma | Carcinoma, Non-Small- Cell LungUnited States, Canada, Spain, France, Germany, Sweden
-
Mayo ClinicNational Cancer Institute (NCI)CompletedMetastatic Adrenal Gland Pheochromocytoma | Malignant Adrenal Gland Pheochromocytoma | Malignant ParagangliomaUnited States
-
Genentech, Inc.Active, not recruitingMelanomaUnited States, Germany, Australia, Korea, Republic of, Canada, Norway
-
Incyte CorporationActive, not recruitingCervical Cancer | Nasopharyngeal Carcinoma | Advanced Solid Tumors | Mesothelioma | Small-cell Lung Cancer | Esophageal Squamous Cell Carcinoma | Merkel Cell Carcinoma | Sarcomatoid Renal Cell Carcinoma | Anal Carcinoma | Cutaneous Squamous Cell Carcinoma | MSI-H/dMMR Tumors | PD-L1 Amplified Tumor (9p24.1) | Urothelial... and other conditionsFinland, United States, United Kingdom, Belgium, Sweden, Denmark, Norway
-
National Cancer Institute (NCI)Active, not recruitingClinical Stage III Cutaneous Melanoma AJCC v8 | Mucosal Melanoma | Acral Lentiginous Melanoma | Clinical Stage IV Cutaneous Melanoma AJCC v8United States
-
Melanoma Institute AustraliaMerck Sharp & Dohme LLCActive, not recruitingMelanoma Stage IIIAustralia
-
University of OxfordCompleted
-
MacroGenicsActive, not recruitingColorectal Cancer | Advanced Cancer | Prostate Cancer Metastatic | Cutaneous Melanoma | Solid Tumor, Adult | Squamous Cell Non Small Cell Lung CancerUnited States, Spain, Bulgaria, Poland, Ukraine
-
Bristol-Myers SquibbActive, not recruitingA Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced CancersMelanoma | CancerUnited States, Poland, Italy, Belgium, France, Australia, Canada, Germany, Spain, Sweden, Switzerland, United Kingdom
-
Xencor, Inc.ICON plcActive, not recruitingRenal Cell Carcinoma | Nasopharyngeal Carcinoma | Small Cell Lung Cancer | Hepatocellular Carcinoma | Advanced Solid Tumors | Non-small Cell Lung Carcinoma | Squamous Cell Carcinoma of the Head and Neck | Cervical Carcinoma | Endometrial Carcinoma | Urothelial Carcinoma | Colorectal Carcinoma | Pancreatic Carcinoma and other conditionsUnited States
-
Hutchison Medipharma LimitedCompletedTumorsUnited States, Italy
-
Merck Sharp & Dohme LLCActive, not recruitingMelanomaCanada, United States, Australia, Belgium, Brazil, Chile, France, Germany, Israel, Italy, Japan, Poland, South Africa, Spain, Switzerland, United Kingdom
-
HutchmedActive, not recruitingNeuroendocrine Tumours | Neuroendocrine Tumour of the Lung | Small Intestinal NETSpain, France, United States, United Kingdom, Norway, Germany, Italy
-
HutchmedBeiGeneActive, not recruitingSoft Tissue Sarcoma | Small Cell Lung Cancer | Gastric Cancer | Colorectal Cancer | Neuroendocrine Tumors | Metastatic Solid Tumor | Anaplastic Thyroid CancerUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingGastrinoma | Glucagonoma | Insulinoma | Pancreatic Polypeptide Tumor | Recurrent Islet Cell Carcinoma | Somatostatinoma | Islet Cell CarcinomaUnited States
-
Cancer Research UKBicycle TherapeuticsCompletedNon-Small Cell Lung Cancer | Advanced Solid Tumours | Oesophageal Cancer | Non-Small Cell Lung SarcomaUnited Kingdom
-
National Cancer Institute (NCI)CompletedMultiple Endocrine Neoplasia Type 2A | Multiple Endocrine Neoplasia Type 2B | Recurrent Thyroid Gland Medullary Carcinoma | Hereditary Thyroid Gland Medullary Carcinoma | Locally Advanced Thyroid Gland Medullary Carcinoma | Sporadic Thyroid Gland Medullary Carcinoma | Stage III Thyroid Gland Medullary... and other conditionsUnited States
-
Dana-Farber Cancer InstituteBristol-Myers SquibbActive, not recruitingAdrenocortical Carcinoma | Penile Cancer | Genitourinary Cancer | Non-urothelial Bladder | Non-urothelial Upper Tract | Non-adenocarcinoma Prostate Cancer | Refractory Germ-cell | High Grade Neuroendocrine Carcinoma/Small Cell CarcinomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Stage IIIC Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7United States
-
Regeneron PharmaceuticalsBristol-Myers SquibbActive, not recruitingMelanoma | Metastatic Melanoma | Unresectable Melanoma | Advanced MelanomaUnited States
-
Reata, a wholly owned subsidiary of BiogenAbbVieCompletedMetastatic or Incurable Non-small Cell Lung Cancer | Relapsed, Refractory MelanomaUnited States
-
Reata, a wholly owned subsidiary of BiogenWithdrawn
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; Novartis; Dana-Farber Cancer InstituteCompletedNeuroendocrine TumorsUnited States
-
Zhuhai Beihai Biotech Co., LtdCompleted
-
University of ChicagoMerck Sharp & Dohme LLC; Evelo Biosciences, Inc.Suspended
-
Highlight TherapeuticsMerck Sharp & Dohme LLCActive, not recruiting
-
AstraZenecaActive, not recruitingSolid TumorsBelgium, United Kingdom, Switzerland, Australia
-
Merck Sharp & Dohme LLCActive, not recruitingMelanomaUnited States, Australia, France, Israel, Italy, Switzerland
-
Providence Health & ServicesExelixis; Advanced Accelerator Applications SAActive, not recruitingNeuroendocrine TumorsUnited States
-
AstraZenecaCompletedSolid TumourUnited States
-
PfizerCompletedBRAF or NRAS Mutant Metastatic MelanomaUnited States, Netherlands, Italy, Germany, Switzerland
-
McGill University Health Centre/Research Institute...St. Joseph's Healthcare Hamilton; University of British Columbia; University... and other collaboratorsActive, not recruitingMicroscopic Polyangiitis | Granulomatosis With Polyangiitis | ANCA-associated VasculitisCanada
-
Immunocore LtdAstraZenecaCompletedMalignant MelanomaUnited States
-
AstraZenecaActive, not recruitingMelanomaFrance, Germany, Italy, Spain, Belgium, Canada, Poland, Korea, Republic of, United Kingdom, United States, Australia
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)Active, not recruiting
-
Novartis PharmaceuticalsCompletedMelanomaUnited States, Italy, United Kingdom, Netherlands, Canada, Germany, Australia, Spain, Switzerland, France
-
Cellestia Biotech AGTerminatedBreast Cancer | Adenoid Cystic Carcinoma | Hepatocellular Carcinoma | Colorectal Cancer | Osteosarcoma | Non-hodgkin Lymphoma | Glomus Tumor, Malignant | T-ALLUnited States, Spain, Korea, Republic of, Germany, France, Switzerland